RITUXIMAB OBJECTIVE OUTCOME MEASURES TRIAL IN SLE (ROOTS): A DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED FEASIBILITY TRIAL

被引：0
|
作者：
Mahmoud, K. [1 ,2 ]
Wilson, M. [1 ,2 ]
Yusof, M. Y. Md [1 ,2 ]
Brown, S. [3 ]
Hensor, E. [1 ,2 ]
Vital, E. [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS trust, NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Randomized control trial; Systemic lupus erythematosus; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.7022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB0005
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [21] First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
    Hermann, Viktoria
    Batalov, Anastas
    Smakotina, Svetlana
    Juif, Pierre-Eric
    Cornelisse, Peter
    LUPUS SCIENCE & MEDICINE, 2019, 6 (01):
  • [22] Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
    Tam, LS
    Li, EK
    Wong, CK
    Lam, CWK
    Szeto, CC
    LUPUS, 2004, 13 (08) : 601 - 604
  • [23] Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study
    Miyasaka, Nobuyuki
    Kawai, Shinichi
    Hashimoto, Hiroshi
    MODERN RHEUMATOLOGY, 2009, 19 (06) : 606 - 615
  • [24] Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial
    Doerner, Thomas
    van Vollenhoven, Ronald F.
    Doria, Andrea
    Jia, Bochao
    Terres, Jorge A. Ross
    Silk, Maria E.
    de Bono, Stephanie
    Fischer, Peter
    Wallace, Daniel J.
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [25] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Anca D. Askanase
    Enxu Zhao
    Julie Zhu
    Roman Bilyk
    Richard A. Furie
    Rheumatology and Therapy, 2020, 7 : 893 - 908
  • [26] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Askanase, Anca D.
    Zhao, Enxu
    Zhu, Julie
    Bilyk, Roman
    Furie, Richard A.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 893 - 908
  • [27] Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial
    Thomas Dörner
    Ronald F. van Vollenhoven
    Andrea Doria
    Bochao Jia
    Jorge A. Ross Terres
    Maria E. Silk
    Stephanie de Bono
    Peter Fischer
    Daniel J. Wallace
    Arthritis Research & Therapy, 24
  • [28] A Randomized, Double-blind, Placebo-controlled Clinical Trial Examining the Effects of Green Tea Extract on Systemic Lupus Erythematosus Disease Activity and Quality of Life
    Shamekhi, Z.
    Amani, R.
    Habibagahi, Z.
    Namjoyan, F.
    Ghadiri, Ata
    Malehi, A. Saki
    PHYTOTHERAPY RESEARCH, 2017, 31 (07) : 1063 - 1071
  • [29] Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial
    Salmon, Jane
    Wallace, Daniel J.
    Rus, Violeta
    Cox, Addison
    Dykas, Claire
    Williams, Brooke
    Ding, Yunpeng
    Hals, Petter-Arnt
    Johnsen, Line
    Lipsky, Peter E.
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [30] The effect of green coffee extract supplementation on serum oxidized LDL cholesterol and total antioxidant capacity in patients with dyslipidemia: A randomized, double-blind, placebo-controlled trial
    Salamat, Shekoufeh
    Sharif, Saeid Sadeghian
    Nazary-Vanani, Ali
    Kord-Varkaneh, Hamed
    Clark, Cain C. T.
    Mohammadshahi, Majid
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2019, 28 : 109 - 113
12345